Background: Humidifier disinfectant-related lung injury (HDLI) is a severe form of toxic inhalational pulmonary parenchymal damage found in residents of South Korea previously exposed to specific guanidine-based compounds present in humidifier disinfectants (HD). HD-associated asthma (HDA), which is similar to irritant-induced asthma, has been recognized in victims with asthma-like symptoms and is probably caused by airway injury. In this study, diffusing capacity of the lung for carbon monoxide (DL) in individuals with HDA was compared to that in individuals with pre-existing asthma without HD exposure.
Methods: We retrospectively compared data, including DL values, of 70 patients with HDA with that of 79 patients having pre-existing asthma without any known exposure to HD (controls). Multiple linear regression analysis and logistic regression analysis were performed to confirm the association between HD exposure and DL after controlling for confounding factors. The correlation between DL and several indicators related to HD exposure was evaluated in patients with HDA.
Result: The mean DL was significantly lower in the HDA group than in the control group (81.9% vs. 88.6%; = 0.021). The mean DL of asthma patients with definite HD exposure was significantly lower than that of asthma patients with lesser exposure ( for trend = 0.002). In multivariable regression models, DL in the HDA group decreased by 5.8%, and patients with HDA were 2.1-fold more likely to have a lower DL than the controls. Pathway analysis showed that exposure to HD directly affected DL values and indirectly affected its measurement through a decrease in the forced vital capacity (FVC). Correlation analysis indicated a significant inverse correlation between DL% and cumulative HD exposure time.
Conclusion: DL was lower in patients with HDA than in asthma patients without HD exposure, and decreased FVC partially mediated this effect. Therefore, monitoring the DL may be useful for early diagnosis of HDA in patients with asthma symptoms and history of HD exposure.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667013 | PMC |
http://dx.doi.org/10.3346/jkms.2022.37.e319 | DOI Listing |
Retina
December 2024
The Retina Clinic London, 140 Harley Street, London W1G 7LB, United Kingdom.
Purpose: Propose new terminology and evaluate the effectiveness of Therapeutic Refractive Vitrectomy (TRV) for selective removal of vitreous floaters and opacities (VFO) utilizing Standardized Kinetic Anatomical Functional Testing of VFO (SK VFO Test) and new ultra widefield (UWF) OCT imaging techniques.
Methods: Retrospective analysis. Twenty eyes underwent TRV for symptomatic VFO.
J Shoulder Elbow Surg
December 2024
Department of Orthopaedic and Trauma Surgery, San Pietro Fatebenefratelli Hospital, 00189 Rome, Italy; Faculty of Medicine and Surgery, Link Campus University, 00165 Rome, Italy.
Introduction: The focus in reverse shoulder arthroplasty (RSA) has been on the lateralization and distalization of prosthesis positioning, influenced by implant design and surgical technique. There's no consensus on the optimal amount of lateralization and distalization or the best radiographic parameters for evaluating placement. This study examines the correlation and the predictive value between previously described modified distalization shoulder angle (DSA) and lateralization shoulder angle (LSA) with postoperative outcomes, which aim to differentiate the contributions of the humeral and glenoid components in the global distalization and lateralization of the RSA.
View Article and Find Full Text PDFRheumatol Ther
November 2024
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Introduction: While modern treatments can prevent progressive bone destruction in patients with rheumatoid arthritis (RA) achieving clinical remission, it is unclear whether residual clinical activity may cause or be associated with progressive joint damage. This post hoc analysis evaluated the association between clinical disease activity and structural progression in patients with RA treated with filgotinib (FIL) in FINCH 1 (NCT02889796).
Methods: Patients with RA and inadequate response to methotrexate (MTX) use were randomized 3:3:2:3 to FIL 200 mg (FIL200) or FIL 100 mg (FIL100) once daily, adalimumab 40 mg biweekly, or placebo, all with background MTX.
Rheumatol Adv Pract
November 2024
AbbVie Limited, Dublin, Ireland.
Objectives: CONTExT-RA is a cross-sectional, non-interventional multicentre study which enrolled patients diagnosed with RA and receiving DMARD treatment in a secondary care setting. The study evaluated disease control and associated disease burden amongst this Irish population.
Methods: Patients with RA attending six Irish rheumatology centres were invited to participate.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!